On 10th May 1-2pm we'll be welcoming Richard Thorpe from East Staffordshire CCG to further capture and share their silver award winning innovative work on their Improving Safe Use of Thickeners in Dysphasia project where he will explain how education around the safe use of thickeners can benefit patients, budgets and working relationships with fellow healthcare professionals.

All NHS registered users can sign up here.

Our brand new CPD certified Polypharmacy and deprescribing e-learning course is now live.

CPD certified logoThe course is broken down into bite sized modules that can be completed at your own time and pace and includes:

  • Definitions, descriptors and principles to ensure appropriate polypharmacy
  • Multimorbidity NICE Guideline NG56
  • Reducing the pill (medicine) burden in people with frailty and those moving towards end of life
  • Medicines optimisation and patient centred care
  • Shared decision making
  • Tools to support medication review
  • Four case studies to bring the theory to life
  • Quizzes for each module and a final assessment.

On successful completion of the course which requires a pass mark of 80% in the final assessment, you'll be issued with a CPD accredited certificate of completion. 

The e-learning package is free to access by subscriber medicines management teams only using a special promo code. If you are a member of a medicines management team, please contact your subscriber lead for details.

Access for other healthcare professionals including practice staff can be purchased either by the CCG/Health Board as a bolt on to subscription, or directly via PayPal by individual users for £12.50.

Subscribers can also download the slidesets and scripts to adapt and deliver training locally from the Polypharmacy and deprescribing webkit

You can access the course after you have logged in from the link under the top 'Learn' menu, from the Polypharmacy and deprescribing webkit or from the link below:

element locked This element is only available to subscribers - if you're a subscriber then please  LOGIN or register to view.
element locked This element is only available to registered NHS users - if you're NHS then please LOGIN or register to view.

 

 

PrescQIPP is governed by the Council of Members. This group provides strategic oversight, ensures that the organisation is run for the benefit of the community, and is the ultimate decision making body. The council is made up of commissioners from the PrescQIPP community, the PrescQIPP board of directors, and expert members and is supported by the company secretary.

We have now published our terms of reference for the group, which is available via the Governance page.

The controlled drugs bulletin and resources have been written to support CCG teams that have a role in supporting the regional NHS England Controlled Drugs Accountable Officer (CDAO). 

An audit tool, standard operating procedure template and letters are available to adapt and use as supporting resources. All our controlled drugs resources will also be available on the controlled drugs webkit which includes the CD monitoring datasets. 

Info_bulletin_SQ_preopt.png   Controlled drugs monitoring

We're looking for an exceptional person to join our operational team for the role of Insights Analyst. This role will focus on joining together PrescQIPP's growing infrastructure, to improve our reporting, communications and website intelligence. This role will seek to further support our subscribers by finding smarter, more joined up and efficient ways of working.

The advert can be found below, we'll be looking for any candidates to start no later than the end of May.

zip.png PrescQIPP Insights Analyst Vacancy

Please contact liam@prescqipp.info for more information.

On 6th June 1-2pm we'll be welcoming Finlay Royle from Lambeth CCG to further capture and share their award winning innovative work on their ‘Optimising Medicines for COPD and Asthma – An Integrated Approach’ project. Over-prescribing of high-dose inhaled corticosteroids is causing avoidable harm in asthma and COPD. Diagnostic spirometry is often poorly performed and interpreted, and there is a lack of investment in high-value interventions such as pulmonary rehabilitation and treatments for tobacco addiction.

This webinar will describe how commissioning levers were utilised to: reduce inappropriate prescribing of inhaled corticosteroids; invest in high-value interventions (such as pulmonary rehabilitation) and; improve accuracy and consistency of diagnostic spirometry.

All NHS registered users can sign up here.

It's that time of year once again where we publish our work plan for the coming year, and we've got a great one planned for 2017/18. The work plan features some of the firm favourite outputs from PrescQIPP such as more DROP-list, polypharmacy and deprescribing, biosimilars and the large therapeutic areas such as diabetes and respiratory, along with a number of new projects looking at the practical application of skills and competency training in local areas. The workplan is available below:

Survey_C.png PrescQIPP Work Plan 2017/18

The TARGET Antibiotics Toolkit - Guide to Resources has recently been updated - you can view the guide to resources and supporting documens in the TARGET Antibiotics slider below.

Bulletin 152  - IMPACT (polypharmacy) is now available to all PrescQIPP users.

The Improving Medicines and Polypharmacy Appropriateness Clinical Tool (IMPACT) updates and replaces the Optimising Safe and Appropriate Medicines Use (OSAMU) tool. This tool forms the overarching clinical advice for our polypharmacy and deprescribing work stream and will be underpinned by practical implementation tools through our future work.

  Polypharmacy - IMPACT